Siddharth Kaul
Director/Miembro de la Junta en IMMUNOCORE HOLDINGS PLC .
Fortuna: - $ al 31/05/2024
Origen de la red de primer grado Siddharth Kaul.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.
13
| Holding Company | Pharmaceuticals: Major | 13 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
| Public Company | Pharmaceuticals: Major | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Siddharth Kaul a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Helsinn Holding SA
 Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Director/Board Member Chief Executive Officer Founder Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
Helsinn Healthcare SA /Venture/
 Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor Chairman Private Equity Investor Private Equity Investor | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | President Corporate Officer/Principal Corporate Officer/Principal | |
Helsinn Birex Pharmaceuticals Ltd.
 Helsinn Birex Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Helsinn Birex Pharmaceuticals Ltd. develops and manufactures oral dosage drug products. It is engaged in providing oral solid dosage forms and topical forms of pharmaceutical products and packaging of sterile products. The firm supplies its partners with ready to sell products on an exclusive basis, which are manufactured on site and using a network of external manufacturing partners. The company was founded by Gabriele Braglia on May 18, 1978 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Founder | |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Founder Founder | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree Doctorate Degree | |
| Helsinn SA | Director/Board Member Chairman | ||
Greenbone Ortho SRL
 Greenbone Ortho SRL BiotechnologyHealth Technology Greenbone Ortho SRL develops a wood-derived bone implants technology to generate biomimetic implant suitable to address non-union fractures. It offers GreenBone that reproduce chemical composition and thee-dimensional architecture of natural tissues. The company was founded by Lorenzo Pradella in 2014 and is headquartered in Faenza, Italy. | Biotechnology | Director/Board Member Director/Board Member | |
QuantuMDx Group Ltd.
 QuantuMDx Group Ltd. Electronic Equipment/InstrumentsElectronic Technology QuantuMDx Group Ltd. develops devices for diagnostics detection. The firm offers DNA-XT, Under The Tree Diagnostics, Q-POC, and Internet of Life. The company was founded by Jonathan O'Halloran, Elaine Warburton, and Julian Warburton in March 2008 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
Eisai Corp. of North America
 Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Corp. of North America is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| Greater Philadelphia Life Sciences Congress | Director/Board Member | ||
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | President | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member | |
| VALERITAS INC | Medical Specialties | Chief Executive Officer | |
| University of Illinois At Urbana–Champaign | College/University | Masters Business Admin | |
| VALERITAS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
| Smilow Cancer Hospital Care Center | Corporate Officer/Principal | ||
| Ensign College | College/University | Corporate Officer/Principal | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal | |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Corporate Officer/Principal | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| International Association for the Study of Lung Cancer | Director/Board Member | ||
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Rockefeller University | College/University | Doctorate Degree | |
| Yale University | College/University | Graduate Degree | |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 39 |
| Reino Unido | 4 |
| Suiza | 3 |
| Irlanda | 3 |
| Luxemburgo | 2 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 12 |
| Health Services | 4 |
| Commercial Services | 4 |
| Finance | 3 |
Operativa
| Director/Board Member | 176 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 47 |
| Chairman | 25 |
| Founder | 21 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Robert Perez | 31 |
| Lonnie Moulder | 31 |
| Riccardo Braglia | 30 |
| John Bell | 27 |
| Mary Lynne Hedley | 25 |
| Francesco Granata | 24 |
| Srikant T. Madhav Datar | 19 |
| Kristine Peterson | 18 |
| Roberto de Ponti | 16 |
| Bahija Jallal | 16 |
| Roy Herbst | 16 |
| Bertrand Bodson | 14 |
| Eric Cornut | 14 |
| Brian DiDonato | 13 |
| Carlos von Bonhorst | 10 |
- Bolsa de valores
- Insiders
- Siddharth Kaul
- Conexiones Empresas
